Telephone
61.3.9664.1300
Address
Level 2 161 Collins Street Melbourne, Victoria (VIC) 3000
Description
Cogstate Ltd. is a global cognitive science company. It delivers software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company operates through the following segments: Clinical Trials, Healthcare and Academic Research. The Clinical Trials segment provides solutions to optimize clinical outcome assessments to better measure drug efficacy and safety. The Healthcare segment provides tools to detect patient cognitive impairment and change throughout the continuum of care. The Academic Research provides Technology for researchers studying cognition, from academics to public-private partnerships. Cogstate was founded by David Gordon Darby and Paul Maruff on December 17, 1999 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.13 - 2.45
Trade Value (12mth)
US$69,996.00
1 week
-3.69%
1 month
-2.05%
YTD
-25.45%
1 year
-22.22%
All time high
2.68
EPS 3 yr Growth
-267.800%
EBITDA Margin
12.10%
Operating Cashflow
$1m
Free Cash Flow Return
3.30%
ROIC
10.10%
Interest Coverage
70.10
Quick Ratio
3.20
Shares on Issue (Fully Dilluted)
176m
HALO Sector
Industrials
Next Company Report Date
28-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.27
Date | Announcements |
---|---|
31 October 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
31 May 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
31 August 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
30 October 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
30 November 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
30 May 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
30 January 17 |
Investor Presentation
×
Investor Presentation |
30 August 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
30 August 22 |
Securities Trading Policy
×
Securities Trading Policy |
30 August 22 |
FY22 Appendix 4G and Corporate Governance Statement
×
FY22 Appendix 4G and Corporate Governance Statement |
30 August 22 |
Appendix 4E
×
Appendix 4E |
30 August 22 |
Annual Report
×
Annual Report |
30 August 22 |
FY22 Financial Results & Business Outlook
×
FY22 Financial Results & Business Outlook |
30 August 22 |
Cogstate Investor Briefing
×
Cogstate Investor Briefing |
29 September 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
29 November 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
29 May 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
29 July 08 |
UBC Strategic Alliance Presentation
×
UBC Strategic Alliance Presentation |
29 January 18 |
Investor Presentation
×
Investor Presentation |
29 February 16 |
Investor Presentation
×
Investor Presentation |
29 August 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
28 September 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
28 September 23 |
Eisai Japan Dementia Care Support Insurance Announced
×
Eisai Japan Dementia Care Support Insurance Announced |
28 September 23 |
Investor Presentation by Cogstate Executives
×
Investor Presentation by Cogstate Executives |
28 September 22 |
Pause in Trading
×
Pause in Trading |
28 September 22 |
Response to ASX Price Query
×
Response to ASX Price Query |
28 November 23 |
Update - Notification of buy-back - CGS
×
Update - Notification of buy-back - CGS |
28 July 22 |
Business Update and June 2022 Quarter Cashflow
×
Business Update and June 2022 Quarter Cashflow |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.